(Q40787969)

English

Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 September 2017

Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes (English)

1 reference

Europe PubMed Central

23 September 2017

1 reference

based on heuristic

inferred from title

cancer cell line

1 reference

based on heuristic

inferred from title

8

object named as

K Ulbrich

0 references

author name string

B Ríhová

1

1 reference

Europe PubMed Central

23 September 2017

T Etrych

2

1 reference

Europe PubMed Central

23 September 2017

M Pechar

3

1 reference

Europe PubMed Central

23 September 2017

M Jelínková

4

1 reference

Europe PubMed Central

23 September 2017

M Stastný

5

1 reference

Europe PubMed Central

23 September 2017

O Hovorka

6

1 reference

Europe PubMed Central

23 September 2017

M Kovár

7

1 reference

Europe PubMed Central

23 September 2017

K Ulbrich

8

1 reference

Europe PubMed Central

23 September 2017

language of work or name

0 references

publication date

1 July 2001

1 reference

Europe PubMed Central

23 September 2017

Journal of Controlled Release

1 reference

Europe PubMed Central

23 September 2017

74

1 reference

Europe PubMed Central

23 September 2017

225-232

1 reference

Europe PubMed Central

23 September 2017

1-3

1 reference

Europe PubMed Central

23 September 2017

Antiproliferative effect of a lectin- and anti-Thy-1.2 antibody-targeted HPMA copolymer-bound doxorubicin on primary and metastatic human colorectal carcinoma and on human colorectal carcinoma transfected with the mouse Thy-1.2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900320-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900320-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900320-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug-polymer conjugates: potential for improved chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900320-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900320-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting of human and mouse T-lymphocytes by monoclonal antibody-HPMA copolymer-doxorubicin conjugates directed against different T-cell surface antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900320-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody-directed affinity therapy applied to the immune system: in vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900320-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumour tropism and anti-cancer efficacy of polymer-based doxorubicin prodrugs in the treatment of subcutaneous murine B16F10 melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900320-0

7 January 2021

based on heuristic

inferred from DOI database lookup

HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900320-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900320-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug-polymer conjugates containing acid-cleavable bonds

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900320-0

7 January 2021

based on heuristic

inferred from DOI database lookup

New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900320-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The decrease of mitochondrial NADH dehydrogenease and drug induced apoptosis in doxorubicin resistant A431 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900320-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Modifications of oxido-reductase activities in adriamycin-resistant leukaemia K562 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900320-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-3659(01)00320-0

1 reference

Europe PubMed Central

23 September 2017

1 reference

Europe PubMed Central

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40787969&oldid=1967163048"